CXSS1800008 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(1) | New Drug Application | 2018-04-19 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2019-01-03 | view |
CYSB2000225 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2020-10-13 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-12-28 | view |
JXHL2000015 | 注射用IBI362 | mazdutide | Lyophilized | Chemical Drugs(1) | Import Drug Application | 2020-02-15 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-02-14 | view |
CXSL1900040 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2019-04-26 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-04-25 | view |
CXSL1200088 | 重组人-鼠嵌合抗CD20单克隆抗体注射液 | rituximab | Injection | Biological Products(2) | New Drug Application | 2013-02-04 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2014-09-24 | view |
CXSS2100008 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-13 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-12 | view |
CYSB2000189 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2020-08-06 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Approval Completed-Pending Certificated | 2021-11-01 | view |
JXHL1900219 | Pemigatinib片 | pemigatinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-08-23 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-08-22 | view |
CXSL1600128 | 重组全人源抗前蛋白转化酶枯草溶菌素9(PCSK-9)单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2017-02-13 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2017-09-27 | view |
CXSL2000263 | IBI188 | letaplimab | Injection | Biological Products(1) | New Drug Application | 2020-09-12 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-09-11 | view |
CXSL2000008 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(1) | New Drug Application | 2020-01-21 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-01-20 | view |
CXSS1800027 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2018-11-15 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-09-08 | view |
JXHL2000323 | Parsaclisib片 | parsaclisib | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-12-14 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-12-10 | view |
CXSL2000180 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(1) | New Drug Application | 2020-07-04 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-07-02 | view |
JXHL1900199 | Parsaclisib片 | parsaclisib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-08-17 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-08-16 | view |
CXSL1500008 | 重组人血管内皮生长因子受体-抗体-人补体受体1融合蛋白注射液 | | Injection | Biological Products(1) | New Drug Application | 2015-04-21 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-12-22 | view |
CXHL2100071 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
CXSL2000234 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2020-08-12 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-11 | view |
JXHL1900231 | Pemigatinib片 | pemigatinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-09-20 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-09-19 | view |
JXHL2000014 | 注射用IBI362 | mazdutide | Lyophilized | Chemical Drugs(1) | Import Drug Application | 2020-02-15 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-02-14 | view |